glp 1 for sleep apnea Efficacy of GLP-1 Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes GLP1 Drugs Help Protect Against

Patients with atrial arrhythmias had risk factors for occurrence and continuation of arrhythmias: they were significantly older, more often had obesity, a history of AF and LV hypertrophy and were current tobacco users

A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. According to the WHO the rate of obesity worldwide doubled in adults and quadrupled in adolescents between 1990 and 2022

injectable options, and provides key considerations for anyone deciding whether to use a GLP-1 agonist for weight loss

Oral semaglutide likewise resulted in reductions in weight during the trial

More Flavor - Add sesame oil and red pepper flakes to the sauce

Supplementary Information 13741_2024_439_MOESM2_ESM.zip (download ZIP Supplementary Material 2